PLX vs. JXN

Last updated Jun 4, 2026

PLX (Protalix BioTherapeutics, Inc.) and JXN (Jackson Financial Inc.) are both stocks. PLX operates in Biotechnology (Healthcare), while JXN operates in Asset Management (Financial Services). Over the past 3 years, PLX returned -3.92%/yr vs 57.89%/yr for JXN. At a 0.22 correlation, their price movements are largely independent.

Performance

PLX vs. JXN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Protalix BioTherapeutics, Inc. (PLX) and Jackson Financial Inc. (JXN). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, PLX achieves a 8.89% return, which is significantly higher than JXN's -1.28% return.

PLX

• 1D: -1.51%
• 1M: -7.98%
• YTD: 8.89%
• 6M: 13.95%
• 1Y: 22.50%
• 3Y*: -3.92%
• 5Y*: -1.74%
• 10Y*: -13.01%

JXN

• 1D: -1.96%
• 1M: -7.97%
• YTD: -1.28%
• 6M: 6.17%
• 1Y: 27.97%
• 3Y*: 57.89%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

PLX vs. JXN - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
PLX Protalix BioTherapeutics, Inc.	8.89%	-4.26%	5.62%	29.93%	64.72%	-47.69%
JXN Jackson Financial Inc.	-1.28%	26.93%	76.45%	57.22%	-11.54%	34.86%

Correlation

The correlation between PLX and JXN is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.19
Correlation (3Y) Calculated over the trailing 3-year period	0.22
Correlation (All Time) Calculated using the full available price history since Sep 2, 2021	0.22

Fundamentals

EPS PLX : $0.19 JXN : -$7.23
PS Ratio PLX : 2.08 JXN : 0.95
Total Revenue (TTM) PLX : $76.38M JXN : $5.86B
Gross Profit (TTM) PLX : $53.44M JXN : $5.39B
EBITDA (TTM) PLX : $20.91M JXN : -$22.00M

Return for Risk

PLX vs. JXN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PLX

PLX Risk / Return Rank: 53
PLX Sharpe Ratio Rank: 53
PLX Sortino Ratio Rank: 52
PLX Omega Ratio Rank: 52
PLX Calmar Ratio Rank: 54
PLX Martin Ratio Rank: 52

JXN

JXN Risk / Return Rank: 66
JXN Sharpe Ratio Rank: 68
JXN Sortino Ratio Rank: 61
JXN Omega Ratio Rank: 60
JXN Calmar Ratio Rank: 71
JXN Martin Ratio Rank: 71

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PLX vs. JXN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Protalix BioTherapeutics, Inc. (PLX) and Jackson Financial Inc. (JXN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	PLX	JXN	Difference
Sharpe ratio Return per unit of total volatility	0.34	0.88	-0.54
Sortino ratio Return per unit of downside risk	0.92	1.33	-0.40
Omega ratio Gain probability vs. loss probability	1.12	1.17	-0.05
Calmar ratio Return relative to maximum drawdown	0.57	1.72	-1.15
Martin ratio Return relative to average drawdown	1.07	4.02	-2.95
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

PLX vs. JXN - Sharpe Ratio Comparison

The current PLX Sharpe Ratio is 0.34, which is lower than the JXN Sharpe Ratio of 0.88. The chart below compares the historical Sharpe Ratios of PLX and JXN, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	PLX	JXN	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.34	0.88	-0.54
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.03	—	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.16	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.07	0.80	-0.86

Drawdowns

PLX vs. JXN - Drawdown Comparison

The maximum PLX drawdown since its inception was -99.91%, which is greater than JXN's maximum drawdown of -48.34%. Use the drawdown chart below to compare losses from any high point for PLX and JXN.

Drawdown Indicators

	PLX	JXN	Difference
Max Drawdown Largest peak-to-trough decline	-99.91%	-48.34%	-51.57%
Max Drawdown (1Y) Largest decline over 1 year	-39.68%	-16.31%	-23.37%
Max Drawdown (3Y) Largest decline over 3 years	-62.96%	-37.09%	-25.87%
Max Drawdown (5Y) Largest decline over 5 years	-73.21%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-94.37%	—	—
Current Drawdown Current decline from peak	-99.78%	-13.85%	-85.93%
Average Drawdown Average peak-to-trough decline	-93.66%	-15.11%	-78.55%
Ulcer Index Depth and duration of drawdowns from previous peaks	21.01%	6.98%	+14.03%

Volatility

PLX vs. JXN - Volatility Comparison

Protalix BioTherapeutics, Inc. (PLX) has a higher volatility of 13.87% compared to Jackson Financial Inc. (JXN) at 11.64%. This indicates that PLX's price experiences larger fluctuations and is considered to be riskier than JXN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	PLX	JXN	Difference
Volatility (1M) Calculated over the trailing 1-month period	13.87%	11.64%	+2.23%
Volatility (6M) Calculated over the trailing 6-month period	44.36%	23.33%	+21.03%
Volatility (1Y) Calculated over the trailing 1-year period	66.69%	31.89%	+34.80%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	67.72%	44.06%	+23.66%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	79.33%	44.06%	+35.27%

Dividends

PLX vs. JXN - Dividend Comparison

PLX has not paid dividends to shareholders, while JXN's dividend yield for the trailing twelve months is around 3.16%.

Position	TTM	2025	2024	2023	2022	2021
JXN Jackson Financial Inc.	3.16%	3.00%	3.22%	4.84%	6.32%	1.20%
PLX Protalix BioTherapeutics, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

PLX vs. JXN - Profitability Comparison

The chart below illustrates the profitability comparison between Protalix BioTherapeutics, Inc. and Jackson Financial Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

PLX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Protalix BioTherapeutics, Inc. reported a gross profit of 29.62M and revenue of 33.75M. Therefore, the gross margin over that period was 87.8%.

JXN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Jackson Financial Inc. reported a gross profit of 0.00 and revenue of 2.90B. Therefore, the gross margin over that period was 0.0%.

PLX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Protalix BioTherapeutics, Inc. reported an operating income of 21.15M and revenue of 33.75M, resulting in an operating margin of 62.7%.

JXN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Jackson Financial Inc. reported an operating income of 0.00 and revenue of 2.90B, resulting in an operating margin of 0.0%.

PLX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Protalix BioTherapeutics, Inc. reported a net income of 18.32M and revenue of 33.75M, resulting in a net margin of 54.3%.

JXN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Jackson Financial Inc. reported a net income of -435.00M and revenue of 2.90B, resulting in a net margin of -15.0%.

Frequently Asked Questions

Can I hold both PLX and JXN in my portfolio?

PLX and JXN have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, PLX or JXN?

PLX has higher volatility (13.87%) compared to JXN (11.64%). In terms of maximum drawdown, PLX dropped -99.91% vs JXN's -48.34%.

Which has better risk-adjusted returns?

JXN currently has the higher Sharpe Ratio (0.88 vs 0.34), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.